Isodiol International Inc. Announces Binding Agreement to Acquire 25% of Canadian National Pharma Group Inc.
06. Dezember 2017 09:00 ET
|
Isodiol
VANCOUVER, British Columbia, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator...
Isodiol International Acquires Global Rights to produce products under an Innovative Delivery System Patent
17. November 2017 09:25 ET
|
Isodiol
VANCOUVER, British Columbia, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator...